Search results for "0.9"

showing 10 items of 2547 documents

Editorial overview: Fluidity of cell fates – from reprogramming to repair

2021

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CellBiologyCellular ReprogrammingModels BiologicalVirologymedicine.anatomical_structureGeneticsmedicineAnimalsHumansCell LineageReprogrammingDevelopmental BiologyCurrent Opinion in Genetics & Development
researchProduct

Pooled analysis of monocyte distribution width in subjects with SARS‐CoV‐2 infection

2021

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clinical BiochemistryLetter to the EditorsMonocytesLeukocyte CountMDWmedicineDistribution (pharmacology)Humansmonocyte distribution widthLetter to the EditorCell SizeBiochemistry medicalbusiness.industrySARS-CoV-2MonocyteBiochemistry (medical)COVID-19Meta-analysis monocyte distribution width MDW SARS-CoV-2HematologyGeneral MedicinePrognosisVirologyMeta-analysisPooled analysismedicine.anatomical_structurebusinessInternational Journal of Laboratory Hematology
researchProduct

Building a statistical surveillance dashboard for COVID-19 infection worldwide

2020

When a pandemic like the current novel coronavirus (COVID-19) breaks out, it is important that authorities, healthcare organizations and official decision makers, have in place an effective monitoring system to promptly analyze data, create new insights into problematic areas and generate actionable knowledge for fact-based decision making. The aim of this article is to describe an initial work focused on building a comprehensive statistical surveillance dashboard for the epidemic of COVID-19, which can be exploited also for future needs. We propose novel ways of exploring, analyzing and presenting data, using metrics that have not been used previously. We also show the steps necessary to b…

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Dashboard (business)0211 other engineering and technologies02 engineering and technology01 natural sciencesIndustrial and Manufacturing Engineering010104 statistics & probabilitymultiple attribute decision-makingprocess monitoringPandemicHealth carestatistical process control0101 mathematicsSafety Risk Reliability and Quality021103 operations researchbusiness.industrySettore SECS-S/02 - Statistica Per La Ricerca Sperimentale E Tecnologicastatistical decision makingPublic relationsStatistical thinkingstatistical thinkingBusinessDecision analysisDecision analysiQuality Engineering
researchProduct

The effect of climate on the spread of the COVID-19 pandemic: A review of findings, and statistical and modelling techniques

2020

The new SARS-CoV-2 coronavirus has spread rapidly around the world since it was first reported in humans in Wuhan, China, in December 2019 after being contracted from a zoonotic source. This new virus produces the so-called coronavirus 2019 or COVID-19. Although several studies have supported the epidemiological hypothesis that weather patterns may affect the survival and spread of droplet-mediated viral diseases, the most recent have concluded that summer weather may offer partial or no relief of the COVID-19 pandemic to some regions of the world. Some of these studies have considered only meteorological variables, while others have included non-meteorological factors. The statistical and…

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Geography Planning and Development010501 environmental sciencesmedicine.disease_cause01 natural sciencesVirology03 medical and health sciences0302 clinical medicineGeographyPandemicEarth and Planetary Sciences (miscellaneous)medicineGeneral Earth and Planetary Sciences030212 general & internal medicine0105 earth and related environmental sciencesCoronavirusProgress in Physical Geography: Earth and Environment
researchProduct

Attitudes toward the SARS-CoV-2 and Influenza Vaccination in the Metropolitan Cities of Bologna and Palermo, Italy

2021

Vaccine hesitancy (VH) is known to play a relevant role in thwarting the efforts toward reaching satisfactory influenza vaccination coverage, and has caused similar difficulties during the COVID-19 pandemic. This study aims to describe the phenomenon and produce insights on the reasons behind VH. A survey was administered between December 2020 and February 2021 to adults living in the cities of Bologna and Palermo. Of the 443 subjects enrolled, 47.3% were likely to get the influenza vaccination, while 75.6% were willing to receive the COVID-19 vaccination. The most frequent determinants that motivated the willingness to get the COVID-19 vaccine were trust in the safety of vaccines and belie…

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyNegative associationVaccine hesitancy.ArticleEnvironmental healthDrug DiscoveryPandemicMedicinePharmacology (medical)surveyPharmacologybusiness.industrySARS-CoV-2RCOVID-19vaccinationMetropolitan areaVaccinationInfectious DiseasesItalyVaccination coveragevaccine hesitancyMedicinebusinessinfluenzaVaccines
researchProduct

Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.

2021

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020 soon led to the global pandemic of Coronavirus Disease 2019 (COVID-19). Since then, the clinical and scientific communities have been closely collaborating to develop effective strategies for controlling the ongoing pandemic. The game-changing fields of recent years, nanotechnology and nanomedicine have the potential to not only design new approaches, but also to improve existing methods for the fight against COVID-19. Nanomaterials can be used in the development of highly efficient, reusable personal protective equipment, and antiviral nano-coatings in public settings could prevent the spread of SAR…

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pharmaceutical ScienceNanotechnology02 engineering and technologyReview Article03 medical and health sciencesPandemicDiagnosisMedicineHumansNanotechnologyPandemics030304 developmental biology0303 health sciencesbusiness.industrySARS-CoV-2COVID-19021001 nanoscience & nanotechnologyClinical trialNanovaccineImmunizationNanomedicineImmunizationNanocarriers0210 nano-technologybusinessJournal of controlled release : official journal of the Controlled Release Society
researchProduct

Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness

2020

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Plasma AntithrombinSeverity of Illness IndexAntithrombinsCoronavirus Disease 2019medicineHumansThrombophiliaProspective StudiesPlasma Antithrombin Coronavirus Disease 2019 COVID-19business.industryHeparinSARS-CoV-2AntithrombinAnticoagulantsCOVID-19ThrombosisHematologyDisseminated Intravascular CoagulationVirologyCross-Sectional StudiesbusinessCardiology and Cardiovascular Medicinemedicine.drug
researchProduct

Coronavirus disease 2019 infection and the cardiovascular system

2020

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralAntiviral AgentsCardiovascular SystemSettore MED/11Renin-Angiotensin SystemBetacoronavirusPandemicHumansMedicinePandemicsHost Microbial InteractionsbiologySARS-CoV-2business.industryCOVID-19General Medicinebiology.organism_classificationmedicine.diseaseVirologyCOVID-19 Drug TreatmentPneumoniaCardiovascular DiseasesCoronavirus InfectionsCardiology and Cardiovascular MedicinebusinessBetacoronavirusJournal of Cardiovascular Medicine
researchProduct

Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena?

2020

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralAutoimmunityDiseaseComorbiditymedicine.disease_causeAntibodies ViralBiochemistryBetacoronavirusmedicineHumansViral immunologyPandemicsbusiness.industrySARS-CoV-2Molecular MimicryCOVID-19Endothelial CellsCovid 19Cell BiologyMolecular mimicryAcute DiseasebusinessCoronavirus InfectionsNeuroscience
researchProduct

The need for an independent evaluation of the COVID-19 response in Spain.

2020

Spain has been hit hard by COVID-19, with more than 300 000 cases, 28 498 confirmed deaths,1 and around 44 000 excess deaths, as of Aug 4, 2020.2 More than 50 000 health workers have been infected, and nearly 20 000 deaths were in nursing homes.3 With a population of 47 million, these data place Spain among the worst affected countries. Spain is also reported to have one of the best performing health systems in the world4 and ranks 15th in the Global Health Security index.5 So how is it possible that Spain now finds itself in this position?

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralDisaster PlanningBetacoronavirusCorrespondencePandemicmedicineViral therapyHumansPandemicsIndependent evaluationbiologybusiness.industrySARS-CoV-2COVID-19General Medicinemedicine.diseasebiology.organism_classificationVirologyPneumoniaHealthSpainMedicina Preventiva y Salud PúblicabusinessCoronavirus InfectionsDelivery of Health CareBetacoronavirus
researchProduct